Additionally, the prognosis of patients exhibiting high TRIM31 expression was much inferior than that of patients exhibiting low expression, indicating that TRIM31 may serve as a prognostic indicator for GC patients (Fig. 2C). This evidence concerns the gene TRIM31 and gastric cancer.